1. Home
  2. QNCX vs QUIK Comparison

QNCX vs QUIK Comparison

Compare QNCX & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

N/A

Current Price

$0.10

Market Cap

167.0M

Sector

Health Care

ML Signal

N/A

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

N/A

Current Price

$8.57

Market Cap

139.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
QNCX
QUIK
Founded
2012
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
167.0M
139.5M
IPO Year
2019
1997

Fundamental Metrics

Financial Performance
Metric
QNCX
QUIK
Price
$0.10
$8.57
Analyst Decision
Hold
Buy
Analyst Count
3
1
Target Price
$10.00
$11.00
AVG Volume (30 Days)
134.5M
182.5K
Earning Date
05-19-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$20,112,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$70.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$4.26
52 Week High
$4.55
$9.59

Technical Indicators

Market Signals
Indicator
QNCX
QUIK
Relative Strength Index (RSI) 27.56 61.09
Support Level N/A $5.96
Resistance Level $0.98 $9.27
Average True Range (ATR) 0.02 0.60
MACD 0.10 0.08
Stochastic Oscillator 12.00 55.65

Price Performance

Historical Comparison
QNCX
QUIK

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About QUIK QuickLogic Corporation

QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.

Share on Social Networks: